Maven Securities LTD Shattuck Labs, Inc. Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$1.37 - $7.24 $868,410 - $4.59 Million
633,876 New
633,876 $4.52 Million
Q1 2021

May 17, 2021
SELL
$27.92 - $52.5 $4.19 Million - $7.88 Million
-150,000 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$19.0 - $57.61 $2.85 Million - $8.64 Million
150,000 New
150,000 $7.95 Million

Others Institutions Holding STTK

# of Institutions
80
Shares Held
28.8M
Call Options Held
300
Put Options Held
1.2K
View Full List

About Shattuck Labs, Inc.

STTK Quotes by TradingView
  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $55.1M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email